Full Text
EE405 A UK Cost-Minimisation Analysis of Brolucizumab Versus Aflibercept in Diabetic Macular Oedema (DMO)

Abstract

Authors

S Sydnor M Ibrahim I Singh U Vudumula L Marshall E Hancock C Bandeiras F Felizzi

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×